found that tumor‐infiltrating CCR8+ Tregs are significantly upregulated in CRCs (Figure 1),77 similar to previous research in breast78 and lung cancer,30 and mAb therapy targeting CCR8 could obviously inhibit tumor growth and improve the prognosis in CRCs mouse models by increasing tumor‐specific T cells. This evidence concerns the gene CCR8 and lung cancer.